The next time your doctor prescribes a blood test, don’t be surprised if an Amazon executive rings your doorbell.
Yes, the e-commerce giant is entering India’s $15 billion diagnostics space with a brand-new offering: Amazon Diagnostics.
This isn’t just a small experiment. It’s Amazon’s first-ever diagnostics venture globally, and India is the launchpad.
A Trifecta of Healthcare Disruption
Amazon already has its foot in Indian healthcare through Amazon Pharmacy and Amazon Clinic. With diagnostics, it completes the “outpatient loop” — allowing customers to consult doctors, get tests done, and order medicines — all from one app.
Partnering with Orange Health Labs, Amazon promises 60-minute doorstep sample collection and digital test results in under 6 hours. Launching across major cities like Delhi, Mumbai, Bengaluru, and Hyderabad, it’s ready to disrupt a space dominated by players like Dr. Lal PathLabs, Metropolis, and Thyrocare.
Why Now? Why Diagnostics?
India’s diagnostics industry is booming — growing at 14% CAGR and expected to touch $25 billion by FY28. But it’s also highly fragmented: standalone labs hold nearly half the market, while national chains command just 6-15%. That’s exactly the kind of broken system Amazon loves to fix.
According to Amazon Medical’s Jayaramakrishnan Balasubramanian, “Healthcare is a daily need, second only to grocery. And diagnostics was the missing link.”
Read more: The Trump stamp: From moths and mansions to mobile phones
More Than Just Tests: A Platform Strategy
Amazon’s goal isn’t to undercut prices — it’s to build an integrated, tech-driven, convenient healthcare ecosystem. It brings AI, logistics expertise, real-time booking, secure report delivery, and app-based service tracking — all strengths Amazon has mastered elsewhere.
With this move, Amazon isn’t just entering diagnostics — it’s redefining what Indian consumers should expect from healthcare.
